<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Immunol.</journal-id>
<journal-title>Frontiers in Immunology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Immunol.</abbrev-journal-title>
<issn pub-type="epub">1664-3224</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fimmu.2025.1633390</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Immunology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>PLC&#x3b3;2 controls neutrophil-like cell sensitivity through calcium oscillation and gates chemoattractant concentration range for chemotaxis</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Xu</surname>
<given-names>Xuehua</given-names>
</name>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/420433/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/project-administration/"/>
<role content-type="https://credit.niso.org/contributor-roles/resources/"/>
<role content-type="https://credit.niso.org/contributor-roles/software/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
<role content-type="https://credit.niso.org/contributor-roles/visualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kim</surname>
<given-names>Woo Sung</given-names>
</name>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lee</surname>
<given-names>Arthur</given-names>
</name>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Jin</surname>
<given-names>Tian</given-names>
</name>
<uri xlink:href="https://loop.frontiersin.org/people/1197159/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
</contrib-group>
<aff id="aff1">
<institution>Chemotaxis Signaling Section, Laboratory of Immunogenetics, National Institute of Allergy and Infectious Diseases, National Institutes of Health</institution>, <addr-line>Rockville, MD</addr-line>,&#xa0;<country>United States</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Zhichao Fan, UCONN Health, United States</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Alan Y. Hsu, Harvard Medical School, United States</p>
<p>Guoshun Wang, State University Health Sciences Center, United States</p>
<p>Karolina Najder, University of M&#xfc;nster, Germany</p>
</fn>
<fn fn-type="corresp" id="fn001">
<p>*Correspondence: Xuehua Xu, <email xlink:href="mailto:xxu@niaid.nih.gov">xxu@niaid.nih.gov</email>
</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>01</day>
<month>08</month>
<year>2025</year>
</pub-date>
<pub-date pub-type="collection">
<year>2025</year>
</pub-date>
<volume>16</volume>
<elocation-id>1633390</elocation-id>
<history>
<date date-type="received">
<day>22</day>
<month>05</month>
<year>2025</year>
</date>
<date date-type="accepted">
<day>17</day>
<month>07</month>
<year>2025</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2025 Xu, Kim, Lee and Jin.</copyright-statement>
<copyright-year>2025</copyright-year>
<copyright-holder>Xu, Kim, Lee and Jin</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<p>The relationship between calcium oscillation and cell sensitivity is poorly understood. Calcium oscillation can occur spontaneously or be triggered upon receptor-ligand binding. The cytosolic [Ca<sup>2+</sup>] increase during calcium oscillation is initiated from Ca<sup>2+</sup> release from the intracellular stores through the phospholipase C (PLC)-derived inositol 1,4,5-trisphosphate (IP<sub>3</sub>). Here, we show that neutrophil-like HL60 cells lacking PLC&#x3b3;2 (<italic>plcg2<sup>kd</sup>
</italic>) exhibit impaired spontaneous calcium oscillation and a diminished calcium response to chemoattractant stimulation. These defects result in reduced membrane targeting of RasGAP CAPRI (calcium-promoted Ras inactivator), and subsequent elevated Ras activations and enhanced downstream signaling, including PI<sub>3</sub>K&#x3b3; activation and actin polymerization. Notably, <italic>plcg2<sup>kd</sup>
</italic> cells display increased sensitivity and can respond to chemoattractant gradients at a subsensitive concentrations. Taken together, our findings identify PLC&#x3b3;2 as a key regulator of spontaneous and chemoattractant-induced calcium signaling and demonstrate its essential role in controlling cell sensitivity and chemoattractant concentration range for chemotaxis through CAPRI-dependent Ras signaling.</p>
</abstract>
<kwd-group>
<kwd>chemotaxis</kwd>
<kwd>neutrophil sensitivity</kwd>
<kwd>G protein coupled receptor (GPCR)</kwd>
<kwd>PLC gamma 2</kwd>
<kwd>calcium oscillation and calcium signaling</kwd>
<kwd>calcium promoted Ras inactivator (CAPRI)</kwd>
</kwd-group>
<counts>
<fig-count count="7"/>
<table-count count="0"/>
<equation-count count="0"/>
<ref-count count="34"/>
<page-count count="14"/>
<word-count count="7407"/>
</counts>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-in-acceptance</meta-name>
<meta-value>Molecular Innate Immunity</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="intro">
<title>Introduction</title>
<p>Calcium oscillation is ubiquitous, triggered either spontaneously or upon receptor-ligand binding in cells. They arise from coordinated intracellular Ca<sup>2+</sup> release and extracellular Ca<sup>2+</sup> influx. Intracellular Ca<sup>2+</sup> is typically released via inositol 1,4,5-trisphosphate (IP<sub>3</sub>), a second messenger produced by phospholipase C (PLC), while extracellular Ca<sup>2+</sup> enters through store-operated channels (SOCs) in the plasma membrane. In neutrophils, chemoattractant-induced calcium oscillation, often also called calcium response, were first documented over two decades ago (<xref ref-type="bibr" rid="B1">1</xref>). Genetic studies have shown that PLC&#x3b2;2 and PLC&#x3b2;3 are essential for this response, as their deletion markedly impairs calcium signaling in neutrophils (<xref ref-type="bibr" rid="B2">2</xref>). Beyond the calcium signaling, PLC&#x3b2;2/&#x3b2;3 also regulate neutrophil polarization and chemotaxis by modulating the cofilin phosphatase slingshot-2 (<xref ref-type="bibr" rid="B3">3</xref>). Moreover, localized calcium pulses help coordinate lamellipodial retraction and adhesion dynamics at the leading edge (<xref ref-type="bibr" rid="B4">4</xref>), linking calcium signaling to cell migration (<xref ref-type="bibr" rid="B1">1</xref>, <xref ref-type="bibr" rid="B5">5</xref>). Despite these insights, the molecular basis of spontaneous calcium oscillations remains unclear. Furthermore, the distinct roles of spontaneous versus chemoattractant-induced calcium signaling in neutrophil behavior&#x2014;and particularly in modulating sensitivity to external cues&#x2014;are not yet well understood.</p>
<p>Phospholipase C gamma (PLC&#x3b3;) is a potent regulator of many signaling pathways that are essential in physiological and pathological responses of immune disorders and cancers (<xref ref-type="bibr" rid="B6">6</xref>). Gain-of-function mutants of PLC&#x3b3;2 have been linked to severe autoimmune and immunodeficiency (<xref ref-type="bibr" rid="B7">7</xref>), while the consequence of PLC&#x3b3;2 deficiency have drawn an increasing attention in recent years (<xref ref-type="bibr" rid="B8">8</xref>&#x2013;<xref ref-type="bibr" rid="B11">11</xref>). Although several studies have suggested a potential link between altered PLC expression and Ras pathway activation, the findings remain contradictory (<xref ref-type="bibr" rid="B12">12</xref>&#x2013;<xref ref-type="bibr" rid="B14">14</xref>). Neutrophils express high level of PLC&#x3b3;2 in addition to PLC&#x3b2;2 and PLC&#x3b2;3 (<xref ref-type="bibr" rid="B15">15</xref>). Tyrosine phosphorylation on Y756 mediates the activation of PLC&#x3b3;2 and plays an essential role in integrin/Fc receptor-mediated neutrophil functions (<xref ref-type="bibr" rid="B16">16</xref>). Interestingly, we have previously found that PLC&#x3b3;2 is robustly recruited to the leading edge of chemotaxing neutrophils-like HL60 cells (<xref ref-type="bibr" rid="B17">17</xref>), while it can undergo unconventional activation via plasma membrane (PM) translocation (<xref ref-type="bibr" rid="B17">17</xref>&#x2013;<xref ref-type="bibr" rid="B19">19</xref>). We further demonstrated that the chemoattractant stimulation does not induce conventional tyrosine phosphorylation at Y756 to activate PLC&#x3b3;2 (<xref ref-type="bibr" rid="B20">20</xref>). Instead, its PM translocation and subsequent activation requires its C2-domain, indicating that C2-calcium binding mediates this process, consistent with the previous reports (<xref ref-type="bibr" rid="B18">18</xref>, <xref ref-type="bibr" rid="B19">19</xref>). In human neutrophil-like cells with stably knocked-down of <italic>plcg2</italic> (<italic>plcg2<sup>kd</sup>
</italic>), an altered PLC signaling, including DAG production and IP<sub>3</sub>-mediated calcium response demonstrates the involvement of PLC&#x3b3;2 in chemoattractant-mediated PLC signaling in HL60 cells (<xref ref-type="bibr" rid="B20">20</xref>). Specifically, <italic>plcg2<sup>kd</sup>
</italic> cells display a significantly reduced duration of calcium response upon chemoattractant stimulation at saturating concentrations of chemoattractant. Neutrophils also highly express CAPRI (Calcium-promoted Ras inactivator), a Ras GTPases-activating protein (RasGAP) containing a calcium-binding C2-domain that facilitates its translocation to plasma membrane upon cytosolic [Ca2<sup>+</sup>] increase (<xref ref-type="bibr" rid="B21">21</xref>). CAPRI serves as a key mediator linking calcium signaling to Ras activation (<xref ref-type="bibr" rid="B22">22</xref>). In <italic>plcg2<sup>kd</sup>
</italic> HL60 cells, impaired calcium signaling leads to defective plasma membrane (PM) recruitment of CAPRI. Reduced CAPRI membrane translocation in <italic>plcg2<sup>kd</sup>
</italic> cells results in elevated and prolonged Ras activation. This sustained Ras activity leads to hyperactivation of PI3K and its downstream effectors, including the PI3K&#x2013;GSK3&#x2013;cofilin axis. Consequently, <italic>plcg2<sup>kd</sup>
</italic> cells exhibit excessive actin polymerization, impaired front&#x2013;rear polarization, and defective chemotaxis (<xref ref-type="bibr" rid="B20">20</xref>). We have also previously shown that CAPRI regulates cell sensitivity and defines the concentration range of chemoattractant gradients for effective chemotaxis (<xref ref-type="bibr" rid="B23">23</xref>). Here, we investigated the role of PLC&#x3b3;2 in spontaneous calcium oscillation, focusing on its effect on PM targeting of CAPRI, Ras activation, and downstream signaling in neutrophils. Our findings demonstrate that PLC&#x3b3;2 not only mediates spontaneous calcium oscillation but also modulates chemoattractant-triggered calcium signaling, thereby regulating cell sensitivity and gating chemoattractant concentration ranges for chemotaxis through membrane CAPRI-dependent Ras signaling.</p>
</sec>
<sec id="s2" sec-type="materials|methods">
<title>Materials and methods</title>
<sec id="s2_1">
<title>Cell culture and differentiation</title>
<p>The culturing of control and <italic>plcg2kd</italic> HL60 cells was as previously reported. Briefly, cells were maintained in RPMI 1640 culture medium [RPMI 1640 medium with 20% (v/v) fetal bovine serum and 25 mM HEPES (Quality Biological, Inc. Gaithersburg, MD)]. HL60 cells were differentiated in RPMI 1640 culture medium containing 1.3% DMSO for 5 days before the experiments. The cells were incubated at 37&#xb0;C in a humidified 5% CO<sub>2</sub> atmosphere.</p>
</sec>
<sec id="s2_2">
<title>Plasmids and transfection of cells</title>
<p>The DNA vectors of turboGFP (tGFP)-human CAPRI, active Ras sensor (active Ras binding domain of human Raf1 tagged with mRFP, RBD-RFP), PIP<sub>3</sub> biosensor (PH-GFP), and PM markers (CAAX-mCherry) were from Addgene (Cambridge, MA). The F-actin sensor F-tractin-GFP was obtained from John Hammer (<xref ref-type="bibr" rid="B24">24</xref>). The transfection procedure was as previously described (<xref ref-type="bibr" rid="B25">25</xref>). Briefly, 2 &#xd7; 10<sup>6</sup> cells were centrifuged at 100 &#xd7; <italic>g</italic> for 10 min and resuspended in a mixture of 80 &#xb5;L nucleofection solution V and 20 &#x3bc;L supplement I at room temperature. Six micrograms of plasmid DNA encoding the cDNA of the desired proteins were used for a single transfection reaction using program T-019 on the Amaxa Nucleofector II (Lonza, MD).</p>
</sec>
<sec id="s2_3">
<title>Calcium response</title>
<p>Cells were incubated with 100 ng/ml Fluo4 (Invitrogen, Carlsbad, CA) at 37&#xb0;C for 30 min, washed with RPMI 1640 medium with 25 mM HEPES twice to remove the unstained Fluo-4, and then subjected to the experiments.</p>
</sec>
<sec id="s2_4">
<title>Ras activation assay</title>
<p>Briefly, cells were starved in RPMI medium containing 25 mM HEPES at 37&#xb0;C for 3 hours. Cells were then collected, resuspended at 2&#xd7;10<sup>7</sup> cells/ml, and transfer to a medical cup under constant shaking at 200 rpm for 3 min at room temperature. Cells were stimulated with fMLP at the indicated final concentrations. At the indicated time points before or after stimulation, 100 &#x3bc;l aliquots of the cells were taken from the shaking medical cup to ensure equal number of cells were subject to the subsequent steps. Aliquots were then mixed with immunoprecipitation buffer (IB), including 0.25% NP40, 10 mM Tris (pH7.5) buffer, 150 mM NaCl, 1 mM Na3VO4, 10 mM NaF, and 1X proteinase inhibitor (Rhoche, Basel, Switzerland). The mixtures were incubated on ice for 30 min and then centrifuged at 100,000 &#xd7; <italic>g</italic> at 4 &#xb0;C for 30 min. The supernatants were incubated with agarose beads conjugated with RBD (active Ras binding domain of human Raf1) (Cytoskeleton, Inc. Denver, CO) at 4&#xb0;C for 2 hours. The agarose beads were washed three times with IB. The protein on the beads was eluted by mixing with 25 &#x3bc;l 2X sample loading buffer (SLD) (Quality Biological Inc, Gaithersburg, MD). The supernatants and eluted proteins were subjected to western blot detection of the indicated proteins.</p>
</sec>
<sec id="s2_5">
<title>Imaging and data processing</title>
<p>Cells were plated and allowed to adhere to the cover glass of a 4-well or a 1-well chamber (Nalge Nunc International, Naperville, IL) precoated with Fibronectin (Sigma Aldrich, Saint Louis, MO) for 10 min, and then covered with RPMI 1640 medium with 10% FBS and 25 mM HEPES. For confocal microscopy, cells were imaged using a Carl Zeiss Laser Scanning Microscope Zen 780 (Carl Zeiss, Thornwood, NY) with a Plan-Apochromat 60x/1.4 Oil DIC M27 objective. For the uniform-stimulation experiment of membrane translocation assays, the stimuli were directly delivered to the cells as previously described (<xref ref-type="bibr" rid="B25">25</xref>). To visualize the application of the stimuli, Alexa 633 or Alexa 488 was mixed with the fMLP stimuli at a final concentration of 1 &#x3bc;g/ml. For calcium response analysis, identical imaging parameters were used for both CTL and <italic>plcg2kd</italic> cells. Fluo-4 fluorescence intensity was measured in individual cells before and after stimulation, and the data were extracted and analyzed using GraphPad Prism. A two-tailed unpaired student <italic>t</italic>-test was used to calculate the <italic>p</italic>-value for the comparisons of peak responses between CTL and <italic>plcg2<sup>kd</sup>
</italic> cells. Statistical significance is indicated as follows: ns (not significant <italic>p</italic> &gt; 0.1), *(<italic>p</italic> &lt; 0.1), **(<italic>p</italic>&#xa0;&lt;&#xa0;0.01), ***(<italic>p</italic> &lt; 0.001). The membrane translocation of the indicated protein was measured by the depletion of the interested protein in the cytoplasm as previously described (<xref ref-type="bibr" rid="B23">23</xref>). The data obtained were further analyzed with Microsoft Office Excel (Redmond, WA). For quantitative analysis of membrane translocation dynamics of the indicated molecules, the cytosolic depletion of the indicated molecule was measured. Regions of interest (ROIs) in the cytoplasm (avoiding the nucleus area as much as possible) were within the cells throughout the time period of the measurements. The periphery of the cells was marked by the membrane markers. For data analysis, to normalize the effect of photobleaching during data acquisition, the intensity of ROIs in the cytoplasm was divided by the intensity of whole cells at each given time point. To normalize the effect of morphological change during the time period, the above resulting data were divided by the intensity of ROIs in the PM marker channel in the case PM marker was simultaneously monitored. Lastly, the resulting data were divided by that at time 0 s; consequently, the relative intensity of any cells at time 0 s became 1. The graph of mean &#xb1; SD is shown.</p>
</sec>
<sec id="s2_6">
<title>TAXIScan chemotaxis assay and data analysis</title>
<p>The procedure was as previously reported (<xref ref-type="bibr" rid="B26">26</xref>). Briefly, differentiated cells were loaded onto fibronectin-coated 4-&#xb5;m EZ-TAXIScan chambers. The chemoattractants at the indicated concentrations were added to the other side of the well across the terrace that the cells chemotax through. The cells migrated for 30 min at 37&#xb0;C. Images were taken at 30-s intervals. For chemotaxis parameter measurements, 20 cells in each group were analyzed with DIAS software (<xref ref-type="bibr" rid="B27">27</xref>). The bar graphs of chemotaxis parameters in mean and SD were plotted with Microsoft Office Excel (Redmond, WA).</p>
</sec>
</sec>
<sec id="s3" sec-type="results">
<title>Results</title>
<sec id="s3_1">
<title>Impaired spontaneous calcium oscillation and chemoattractant-induced calcium response in <italic>plcg2<sup>kd</sup>
</italic> cells</title>
<p>Calcium oscillations are a ubiquitous signaling phenomenon that occurs spontaneously or are triggered by receptor-ligand binding. In this study, we distinguish these two mechanisms by referring to the non-ligand-induced [Ca<sup>2+</sup>] increase as spontaneous calcium oscillation (or calcium oscillation), and the ligand-induced one as calcium response. We previously reported fMLP-induced calcium responses in control (CTL) HL60 cells and <italic>plcg2</italic> stably knocked-down (<italic>plcg2<sup>kd</sup>
</italic>) HL60 cells (<xref ref-type="bibr" rid="B20">20</xref>). Upon saturating fMLP stimulation, both CTL and <italic>plcg2<sup>kd</sup>
</italic> cells exhibited comparable peak calcium. However, <italic>plcg2<sup>kd</sup>
</italic> cells displayed a significantly shorter duration of calcium elevation and a marked reduction in secondary sporadic calcium spikes, suggesting that PLC&#x3b3;2 plays a role in sustaining calcium signaling. To further dissect the function of PLC&#x3b3;2 in calcium response and spontaneous calcium oscillation, we monitored calcium dynamics in both CTL and <italic>plcg2<sup>kd</sup>
</italic> cells upon stimulation with three concentrations of fMLP (10 nM, 1 nM, and 0.1 nM). <italic>plcg2<sup>kd</sup>
</italic> cells exhibit approximately 90% knockdown efficiency of PLC&#x3b3;2, as previously shown (<xref ref-type="bibr" rid="B20">20</xref>). To visualize stimulus application, especially at subsensitive concentrations, we co-applied fMLP with Alexa 633 (red) and monitored calcium signaling using the Fluo-4 indicator (green) (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1</bold>
</xref>). At 10 nM and 1 nM fMLP, both CTL and <italic>plcg2kd</italic> cells exhibited calcium responses (<xref ref-type="fig" rid="f1">
<bold>Figures&#xa0;1A, C</bold>
</xref>, <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Video S1, S2</bold>
</xref>). CTL cells typically show the initial synchronized calcium rise&#x2014;likely corresponding to the chemoattractant-induced response&#x2014;and the subsequent sporadic, asynchronous calcium oscillation observed in individual cells. However, the amplitude and duration of calcium signals were significantly reduced in <italic>plcg2<sup>kd</sup>
</italic> cells (<xref ref-type="fig" rid="f1">
<bold>Figures&#xa0;1B, D</bold>
</xref>). Calcium response in each individual CTL and <italic>plcg2<sup>kd</sup>
</italic> cell further confirms the above observation (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure S1</bold>
</xref>). indicating that PLC&#x3b3;2 contributes to both the amplitude and persistence of GPCR-mediated calcium responses upon stimuli at a moderate ligand concentration. Upon 0.1 nM fMLP stimulation (a subsensitive concentration for CTL cells in the previous report) (<xref ref-type="bibr" rid="B23">23</xref>), neither cell type show synchronized calcium response (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1E</bold>
</xref>, <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Video S3</bold>
</xref>) (<xref ref-type="bibr" rid="B23">23</xref>). Importantly, CTL cells display sporadic calcium responses and spontaneous calcium oscillation as previously described (<xref ref-type="bibr" rid="B1">1</xref>). In contrast, <italic>plcg2<sup>kd</sup>
</italic> cells rarely showed sporadic calcium activity (a representative responses of multiple <italic>plcg2kd</italic> cells shown in <xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1E</bold>
</xref>, lower panel), indicating a critical role of PLC&#x3b3;2 in maintaining spontaneous calcium oscillation under resting conditions. Together, these findings demonstrate that PLC&#x3b3;2 not only constitutes the GPCR-mediated calcium response but also mediates the spontaneous calcium oscillation in the resting neutrophils.</p>
<fig id="f1" position="float">
<label>Figure&#xa0;1</label>
<caption>
<p>Decreased calcium response in <italic>plcg2<sup>kd</sup>
</italic> cells upon fMLP stimulation. <bold>(A)</bold> Montages show a 10 nM fMLP-induced calcium response in control (CTL) and <italic>plcg2</italic>-stably knocked down (<italic>plcg2<sup>kd</sup>
</italic>) cells. Cells stained with the calcium indicator, Fluo-4 (green), were stimulated with fMLP at the indicated concentrations of fMLP at time 0 s. To visualize the application of fMLP stimuli, fMLP was mixed with a fluorescent dye, Alexa 633 (red). Image acquisition conditions of CTL and <italic>plcg2<sup>kd</sup>
</italic> cells are same in <bold>(A, C, D)</bold> Scale bar = 20 &#x3bc;m. For complete sets of cell responses, see <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Video S1</bold>
</xref>. CTL cells are in the upper panel, and <italic>plcg2<sup>kd</sup>
</italic> cells are in the lower panel. The appearance of red indicates the application of fMLP stimulation. <bold>(B)</bold> Dot plot analysis of Fluo-4 intensity change in CTL and <italic>plcg2<sup>kd</sup>
</italic> cells before and after 10 nM fMLP stimulation in <bold>A</bold> and two other independent experiments. N = 10 or 13 for CTL or <italic>plcg2<sup>kd</sup>
</italic> cells, respectively. A two-tailed unpaired student <italic>t</italic>-test was used to calculate the <italic>p</italic>-value for the comparisons of peak responses between CTL and <italic>plcg2<sup>kd</sup>
</italic> cells. Statistical significance is indicated as follows: ns (not significant <italic>p</italic> &gt; 0.05), *(<italic>p</italic> &lt; 0.05), **(<italic>p</italic> &lt; 0.01), ***(<italic>p</italic> &lt; 0.001). The same statistical analysis was applied in <bold>(D, F)</bold>. <bold>(C)</bold> Montages show 1 nM fMLP-induced calcium response in CTL and <italic>plcg2<sup>kd</sup>
</italic> cells. Cells stained with Fluo-4 (green) were stimulated with 1 nM fMLP at time 0 s. To visualize the application of fMLP stimuli, fMLP was mixed with a fluorescent dye, Alexa 633 (red). Scale bar = 20 &#x3bc;m. For complete sets of cell responses, see <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Video S2</bold>
</xref>. CTL cells are in the upper panel, and <italic>plcg2<sup>kd</sup>
</italic> cells are in the lower panel. The appearance of red indicates the application of fMLP stimulation. <bold>(D)</bold> Dot plot analysis of Fluo-4 intensity change in CTL and <italic>plcg2<sup>kd</sup>
</italic> cells before and after 1 nM fMLP stimulation in <bold>C</bold> and the other two independent experiments. N = 14 or 14 for CTL or <italic>plcg2<sup>kd</sup>
</italic> cells, respectively. <bold>(E)</bold> Montages show 0.1 nM fMLP-induced calcium response in CTL and <italic>plcg2<sup>kd</sup>
</italic> cells. For complete sets of cell responses, see <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Video S3</bold>
</xref>. CTL cells are in the upper panel, and <italic>plcg2<sup>kd</sup>
</italic> cells are in the lower panel. The appearance of red indicates the application of fMLP stimulation. Arrows highlight individual cells that display spontaneous, asynchronous calcium oscillations. <bold>(F)</bold> Dot plot analysis of Fluo-4 intensity change in CTL and <italic>plcg2<sup>kd</sup>
</italic> cells before and after 0.1 nM fMLP stimulation in <bold>E</bold> and two other independent experiments. N = 11 or 12 for CTL or <italic>plcg2<sup>kd</sup>
</italic> cells from multiple independent experiments, respectively.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-16-1633390-g001.tif">
<alt-text content-type="machine-generated">Sequential panels showing fluorescence microscopy images (A, C, E) with green and red fluorescence (Fluo4 and fMLP) at various time points (0s to 60s), comparing CTL and plcg2^kd samples at concentrations of 10 nM, 1 nM, and 0.1 nM. Associated line graphs (B, D, F) show Fluo4 intensity against time, indicating differences between CTL and plcg2^kd treatments.</alt-text>
</graphic>
</fig>
</sec>
<sec id="s3_2">
<title>Reduced membrane translocation of CAPRI in <italic>plcg2<sup>kd</sup>
</italic> cells upon fMLP stimulations</title>
<p>The direct connection between calcium oscillation and cell sensitivity to chemoattractant stimulation is unclear. We have previously demonstrated that CAPRI mediates the deactivation of the GPCR-mediated Ras signaling to facilitate Ras adaptation in human neutrophils (<xref ref-type="bibr" rid="B23">23</xref>). In resting neutrophils, CAPRI is predominantly cytosolic; however, a fraction of CAPRI localizes in the plasma membrane (PM), where it regulates basal Ras activity and thereby modulate cell sensitivity. The PM localization of CAPRI depends on its C2-domain and a proper increase in intracellular calcium ([Ca<sup>2+</sup>]). Nonetheless, whether PLC&#x3b3;2 contributes to the calcium increase required for CAPRI membrane recruitment in resting cells has not been fully elucidated. As previously reported (<xref ref-type="bibr" rid="B23">23</xref>), migrating CTL cells actively recruit CAPRI-GFP to the leading fronts, whileas <italic>plcg2<sup>kd</sup>
</italic> cells rarely show CAPRI-GFP enrichment at the protrusion sites (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2A</bold>
</xref>). Upon 10 nM fMLP stimulation, CTL cells display a robust membrane translocation of CAPRI-GFP (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2A</bold>
</xref>, upper panel, and <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Video S4</bold>
</xref>, upper panel). In contrast, <italic>plcg2<sup>kd</sup>
</italic> cells display significantly reduced PM translocation of CAPRI-GFP (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Video S4</bold>
</xref>, lower panel), consistent with the previous report. Upon 0.1 nM fMLP stimulation, neither CTL nor <italic>plcg2<sup>kd</sup>
</italic> cells show detectable CAPRI-GFP membrane translocation (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2C</bold>
</xref>, <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Video S5</bold>
</xref>). While migrating CTL cells consistently localize CAPRI-GFP to the leading fronts, while <italic>plcg2<sup>kd</sup>
</italic> cells do not. We confirmed the above observation in many cells and proceeded to quantify CAPRI plasma membrane (PM) translocation in both CTL and <italic>plcg2<sup>kd</sup>
</italic> cells. To assess membrane translocation quantitatively, we measured cytosolic depletion of CAPRI-GFP as previously reported. Regions of interest (ROIs) were selected in the cytoplasm, avoiding the nucleus area whenever possible, and were tracked throughout imaging period. Due to the migratory behavior of the cells, most of the cells were not suitable for quantitative measurement over time. Therefore, we selected 4 to 5 cells that displayed typical cell response with minimal movement for quantitative analysis. The results shown in <xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2B</bold>
</xref> and <xref ref-type="fig" rid="f2">
<bold>2D</bold>
</xref> support our observations. Collectively, these results indicate that membrane targeting of CAPRI is impaired in <italic>plcg2<sup>kd</sup>
</italic> cells under both resting and stimulated conditions.</p>
<fig id="f2" position="float">
<label>Figure&#xa0;2</label>
<caption>
<p>Reduced membrane translocation of CAPRI in <italic>plcg2<sup>kd</sup>
</italic> cells upon fMLP stimulations. <bold>(A)</bold> Montages show fMLP-induced plasma membrane (PM) translocation of CAPRI-GFP in CTL and <italic>plcg2<sup>kd</sup>
</italic> cells in response to fMLP stimulation at 10 nM. Cells expressing CAPRI-GFP (green) were stimulated with fMLP stimulation at 10 nM at time 0 s. To visualize the application of the stimuli, fMLP was mixed with fluorescent dye, Alexa 633 (red). Scale bar = 10 &#x3bc;m. Arrows indicate the localization of CAPRI-GFP before or after stimulation. See <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Video S4</bold>
</xref> for complete sets of cell responses. The CTL cell is in the upper panel, and the <italic>plcg2<sup>kd</sup>
</italic> cell is in the lower panel. <bold>(B)</bold> Quantitative measurement of the membrane translocation of CAPRI-GFP in CTL and <italic>plcg2<sup>kd</sup>
</italic> cells in response to 10 nM fMLP stimulation. To assess CAPRI-GFP membrane translocation quantitatively, cytosolic depletion of CAPRI-GFP was measured as previously reported (<xref ref-type="bibr" rid="B20">20</xref>). Regions of interest (ROIs) were selected in the cytoplasm, avoiding the nuclear area whenever possible, and were tracked throughout the imaging period. Due to the migratory behavior of the cells, 5 CTL and <italic>plcg2<sup>kd</sup>
</italic> that exhibited typical responses with minimal movement were selected for quantitative analysis. Mean &#xb1; SD is shown; n = 5 or 5 for CTL or <italic>plcg2<sup>kd</sup>
</italic> cells, respectively. <bold>(C)</bold> Montages show fMLP-induced plasma membrane (PM) translocation of CAPRI-GFP in CTL and <italic>plcg2<sup>kd</sup>
</italic> cells in response to fMLP stimulation at 0.1 nM. Cells expressing CAPRI-GFP (green) were stimulated with fMLP stimulation at 0.1 nM at time 0 s. To visualize the application of the stimuli, fMLP was mixed with fluorescent dye, Alexa 633 (red). Arrows indicate the localization of CAPRI-GFP before or after stimulation. Scale bar = 10 &#x3bc;m. See <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Video S5</bold>
</xref> for a complete set of cell responses. CTL cell is in the upper panel and <italic>plcg2<sup>kd</sup>
</italic> cell is in the lower panels. <bold>(D)</bold> Quantitative measurement of the membrane translocation of CAPRI-GFP in CTL and <italic>plcg2<sup>kd</sup>
</italic> cells in response to 0.1 nM fMLP stimulation. The same quantification method used in <xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1B</bold>
</xref> was applied, measuring cytosolic depletion of CAPRI-GFP to assess membrane translocation. Mean &#xb1; SD is shown; n = 5 or 5 for CTL or <italic>plcg2<sup>kd</sup>
</italic> cells, respectively.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-16-1633390-g002.tif">
<alt-text content-type="machine-generated">Fluorescence microscopy images and graphs. Panels A and C show CAPRI translocation in cells over time at 10 nanometer and 0.1 nanometer concentrations of fMLP, respectively, with control and PLC&#x3b3;2^kd conditions. Images include CAPRI, fMLP, and merged views at intervals from 0 to 60 seconds. Panels B and D display graphs of membrane translocation data over time, indicating differences between control and PLC&#x3b3;2^kd cells for each concentration.</alt-text>
</graphic>
</fig>
</sec>
<sec id="s3_3">
<title>Increased Ras activation in <italic>plcg2<sup>kd</sup>
</italic> cells in response to fMLP stimulation at a low or a subsensitive concentration</title>
<p>To investigate the consequence of impaired PM targeting of CAPRI in <italic>plcg2<sup>kd</sup>
</italic> cells, we biochemically assessed Ras activation using a pull-down assay in a large population of both CTL and <italic>plcg2<sup>kd</sup>
</italic> cells upon fMLP stimulation at different concentrations as previously reported (<xref ref-type="bibr" rid="B23">23</xref>). Same amount of CTL and plcg2kd cells were collected and basolated on ice for 10 min. Stimulation at a final concentration of 10 nM fMLP triggered a clear Ras activation in CTL cells, with a significantly stronger activation in <italic>plcg2<sup>kd</sup>
</italic> cells (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3A</bold>
</xref>). In contrast, 0.1 nM fMLP did not trigger notable Ras activation in CTL cells but induced a clear Ras activation in <italic>plcg2<sup>kd</sup>
</italic> cells, indicating increased sensitivity in the cells lacking PLC&#x3b3;2. Densitometric analysis from three independent experiments (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3B</bold>
</xref>) supports this observation. The intensity of active Ras in CTL cells at time 0 s was normalized to 1, and values at other time points are presented as the ratio of intensity at the given time point (I<sub>t</sub>) to that at time 0 (I<sub>0</sub>). To further confirm the increased sensitivity of <italic>plcg2<sup>kd</sup>
</italic> cells, we monitored the temporospatial Ras activation using a live-cell confocal imaging with the active Ras probe (RBD-RFP, red) (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3C</bold>
</xref>). fMLP was co-applied with Alexa488 (green) to visualize the stimulus application. RBD-RFP was found to localize at the protrusion site of both resting CTL and <italic>plcg2<sup>kd</sup>
</italic> cells (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Video S6</bold>
</xref>). Upon 10 nM fMLP stimulation, CTL cells exhibited a robust PM translocation, <italic>plcg2<sup>kd</sup>
</italic> cells showed a significantly stronger and more sustained PM translocation of RBD-RFP, consistent with the previous report (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3C</bold>
</xref>, upper panel, <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Video S6</bold>
</xref>) (<xref ref-type="bibr" rid="B20">20</xref>). When stimulated with 0.1 nM fMLP, CTL cells did not display a marked overall PM translocation of RBD-RFP; instead, RBD-RFP remained localized to the protrusion site or the leading front of a migrating cell (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3C</bold>
</xref>, lower panel, <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Video S7</bold>
</xref>, upper panel). In contrast, <italic>plcg2<sup>kd</sup>
</italic> cells showed a clear PM translocation of RBD-RFP followed by sustained localization at expanding protrusion sites upon the same low-dose fMLP stimulation (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Video S7</bold>
</xref>, lower panel). Quantitative measurement of RBD-RFP membrane translocation across multiple cells further confirms the above observation (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3D</bold>
</xref>). In summary, <italic>plcg2kd</italic> cells exhibit enhanced Ras activation upon chemoattractant stimulation and respond to concentrations of fMLP that are subsensitive for CTL cells. These findings demonstrate that PLC&#x3b3;2 is not only required for chemoattractant-induced Ras adaptation but also plays a critical role in regulating neutrophil sensitivity through CAPRI membrane recruitment.</p>
<fig id="f3" position="float">
<label>Figure&#xa0;3</label>
<caption>
<p>Increased Ras activation in <italic>plcg2<sup>kd</sup>
</italic> cells in response to fMLP stimulation at a low (10 nM) or a subsensitive (0.1 nM) concentration of fMLP. <bold>(A)</bold> Ras activation in CTL and <italic>plcg2<sup>kd</sup>
</italic> cells in response to either 10 nM or 0.1 nM fMLP stimulation was determined by a pull-down assay. <bold>(B)</bold> Normalized quantitative densitometry of the active Ras from three independent experiments, including the result presented in <bold>(A)</bold> The other time points are the ratio of intensity at the given time point (I<sub>t</sub>) vs intensity at time 0 (I<sub>0</sub>) and the intensity of active Ras in CTL cells at time 0 s was normalized to 1. Mean &#xb1; SD from the three independent experiments is shown. <bold>(C)</bold> Montage shows fMLP-induced Ras activation in CTL (left) and <italic>plcg2<sup>kd</sup>
</italic> (right) cells by the membrane translocation of the active Ras biosensor RBD-RFP. Cells expressing RBD-RFP (red) were stimulated with 10 nM (upper panel) or 0.1 nM (lower panel) fMLP at time 0 s. To visualize the application of fMLP, it was mixed with a fluorescent dye, Alexa 488 (green). Arrows indicate the localization of RBD-RFP before or after stimulation. Scale bar = 10 &#x3bc;m. See <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Video S6 or S7</bold>
</xref> (CTL, left panel; <italic>plcg2<sup>kd</sup>
</italic>, right panel) for complete sets of cell responses upon fMLP stimulation at 10 nM or 0.1 nM, respectively. <bold>(D)</bold> Quantitative measurement of PM translocation of RBD-RFP in CTL and <italic>plcg2<sup>kd</sup>
</italic> cells in response to fMLP stimulation at either 10 nM (left) or 0.1 nM (right). Mean &#xb1; SD is shown. N = 4 or 4 for CTL or <italic>plcg2<sup>kd</sup>
</italic> cells, respectively, in both graphs.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-16-1633390-g003.tif">
<alt-text content-type="machine-generated">Composite image illustrating cellular and molecular analyses in control (CTL) and plcg2^kd conditions. Panel A shows a western blot indicating Ras activation levels at different time intervals and concentrations (0.1 nM and 10 nM). Panel B presents a bar graph quantifying Ras activation in both conditions at the same intervals and concentrations as panel A. Panel C provides fluorescence microscopy images showing RBD, fMLP, and merged views at 10 nM and 0.1 nM concentrations, highlighting cellular localization changes over time. Panel D features line graphs tracking RBD translocation over time at 10 nM and 0.1 nM concentrations, comparing CTL and plcg2^kd conditions.</alt-text>
</graphic>
</fig>
</sec>
<sec id="s3_4">
<title>Increased PI<sub>3</sub>K activation in <italic>plcg2<sup>kd</sup>
</italic> cells in response to fMLP stimulation at a low or a subsensitive concentration</title>
<p>PI<sub>3</sub>K&#x3b3;, a direct effector of Ras, catalyzes the conversion of phosphatidylinositol (4,5)-bisphosphate (PI(4,5)P2, PIP<sub>2</sub>) to phosphatidylinositol (3,4,5)-trisphosphate (PtdIns(3,4,5)P3, PIP<sub>3</sub>) (<xref ref-type="bibr" rid="B2">2</xref>, <xref ref-type="bibr" rid="B28">28</xref>, <xref ref-type="bibr" rid="B29">29</xref>). PI<sub>3</sub>K&#x3b3; activation recruits and activates the PIP<sub>3</sub>-binding serine/threonine kinase Akt on the plasma membrane, which plays a critical role in neutrophil chemotaxis (<xref ref-type="bibr" rid="B3">3</xref>). To examine the consequences of the increased Ras activation in <italic>plcg2<sup>kd</sup>
</italic> cells, we next investigated PI<sub>3</sub>K activation in both CTL and <italic>plcg2<sup>kd</sup>
</italic> cells. PI<sub>3</sub>K activation was monitored by visualizing PIP<sub>3</sub> production using a PIP<sub>3</sub> biosensor, PH-GFP, through confocal microscopy. In the resting cells, PH-GFP (green) localizes predominantly in the cytosol (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4A</bold>
</xref>). It also colocalizes with a plasma membrane (PM) marker (red) at the protrusion sites as previous report (<xref ref-type="bibr" rid="B17">17</xref>), which appeared more pronounced in <italic>plcg2<sup>kd</sup>
</italic> cells. Upon 10 nM fMLP stimulation, CTL cells displayed a transient translocation of PH-GFP to the cell periphery, followed by sustained colocalization with the PM marker at protruding sites (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4A</bold>
</xref>, upper panel, <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Video S8</bold>
</xref>). Upon the same stimulation, <italic>plcg2<sup>kd</sup>
</italic> cell shows a significantly stronger and more prolonged PH-GFP translocation to PM (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4A</bold>
</xref>, lower panel; <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Video S8</bold>
</xref>). When stimulated with 0.1 nM fMLP, CTL cells did not show a clear global PM translocation of PH-GFP; instead, PH-GFP remained localized at the protrusion site of migrating cells (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4C</bold>
</xref>, upper panel, <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Video S9</bold>
</xref>). In contrast, <italic>plcg2<sup>kd</sup>
</italic> cells exhibited a clear PM translocation of PH-GFP, followed by continuous localization in the expanding protrusion sites upon the same 0.1 nM fMLP stimulation, (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4C</bold>
</xref>, lower panel, <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Video S9</bold>
</xref>, <xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4D</bold>
</xref>). We confirmed the above observation in many cells and proceeded to quantify PH-GFP PM translocation in both CTL and <italic>plcg2<sup>kd</sup>
</italic> cells. Cytosolic depletion of PH-GFP was measured using the same approach. ROIs in the cytoplasm were selected and tracked over time. To correct for photobleaching, cytoplasmic ROI intensity was normalized to the whole-cell intensity at each time point. To account for morphological changes, the values were further normalized to the intensity of the PM marker channel. Finally, all data were normalized to the intensity at time 0 s, so that the relative intensity at time 0 was set to 1. This quantitative analysis supports our observations (<xref ref-type="fig" rid="f4">
<bold>Figures&#xa0;4B, D</bold>
</xref>). <italic>plcg2<sup>kd</sup>
</italic> cells display a significantly stronger PM translocation of PH-GFP (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure S2</bold>
</xref>). In conclusion, <italic>plcg2kd</italic> cells exhibit elevated PI3K activation and are capable of responding to chemoattractant stimulation at concentrations that are subsensitive for CTL cells.</p>
<fig id="f4" position="float">
<label>Figure&#xa0;4</label>
<caption>
<p>Increased PI<sub>3</sub>K activation in <italic>plcg2<sup>kd</sup>
</italic> cells in response to fMLP stimulation at a low (10 nM) or a subsensitive (0.1 nM) concentration. <bold>(A)</bold> Montage shows PI<sub>3</sub>K activation in CTL and <italic>plcg2<sup>kd</sup>
</italic> cells in response to 10 nM fMLP stimulation by monitoring PIP<sub>3</sub> production using fluorescent microscopy. PIP<sub>3</sub> production is visualized by the membrane translocation of the PIP<sub>3</sub> biosensor PH-GFP. Cells expressing PH-GFP (green) and a PM marker (red) were stimulated with 10 nM fMLP at time 0 s. Arrows indicate the localization of PH-GFP before or after stimulation. Scale bar = 10 &#x3bc;m. See <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Video S8</bold>
</xref> (CTL, upper panel; <italic>plcg2<sup>kd</sup>
</italic>, lower panel) for complete sets of cell responses upon 10 nM fMLP, respectively. <bold>(B)</bold> Quantitative measurement of PIP<sub>3</sub> production by the membrane translocation of PH-GFP in CTL and <italic>plcg2<sup>kd</sup>
</italic> cells in response to 10 nM fMLP stimulation. Mean &#xb1; SD is shown; n = 3 or 5 for CTL or <italic>plcg2<sup>kd</sup>
</italic> cells, respectively. <bold>(C)</bold> Montage shows PI<sub>3</sub>K activation in CTL and <italic>plcg2<sup>kd</sup>
</italic> cells in response to 0.1 nM fMLP stimulation by monitoring PIP<sub>3</sub> production using fluorescent microscopy. Cells expressing PH-GFP (green) and a PM marker (red) were stimulated with 0.1 nM fMLP at time 0 s. Arrows indicate the localization of PH-GFP before or after stimulation. Scale bar = 10 &#x3bc;m. See <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Video S9</bold>
</xref> (CTL, upper panel; <italic>plcg2<sup>kd</sup>
</italic>, lower panel) for complete sets of cell responses upon 0.1 nM fMLP stimulation. <bold>(D)</bold> Quantitative measurement of PIP<sub>3</sub> production by the membrane translocation of PH-GFP in CTL and <italic>plcg2<sup>kd</sup>
</italic> cells in response to 10 nM fMLP stimulation. Mean &#xb1; SD is shown; n = 5 or 5 for CTL or <italic>plcg2<sup>kd</sup>
</italic> cells, respectively.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-16-1633390-g004.tif">
<alt-text content-type="machine-generated">Panel A shows fluorescence microscopy images of cells treated with 10 nM ligand. Two conditions are compared: CTL and plcg2^kd, with green representing PH domain and red representing PM. Arrows indicate points of interest. Panels B and D are line graphs measuring normalized PH translocation over time at 10 nM and 0.1 nM, respectively. Panel C depicts similar images as A but with 0.1 nM ligand. The scale bar indicates 10 micrometers.</alt-text>
</graphic>
</fig>
</sec>
<sec id="s3_5">
<title>Increased actin polymerization in <italic>plcg2<sup>kd</sup>
</italic> cells in response to fMLP stimulation at a low or a subsensitive concentration</title>
<p>Neutrophils utilize GPCR/G protein complexes to regulate multiple signaling pathways that coordinate actin cytoskeleton dynamics and drive cell migration. To evaluate the role of PLC&#x3b3;2 in chemoattractant GPCR-mediated actin assembly in neutrophils, we monitored actin polymerization using a fluorescent F-actin probe, F-tractin&#x2013;GFP (green), in live cells via fluorescence microscopy (<xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5</bold>
</xref>). In resting cells, F-tractin-GFP (green) localizes primarily in the cytosol and cortical regions, where it colocalizes with a plasma membrane (PM) marker (red) on the membrane and protrusion sites (<xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5A</bold>
</xref>). Upon 10 nM fMLP stimulation at 2 s, more F-tractin-GFP translocated to the cell cortex at around 10 to 40 s, then mostly returned to the cytosol at about 60 s, and then translocated to the leading front again at around 80 s in CTL cells (<xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5A</bold>
</xref>, upper panel, <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Video S10</bold>
</xref>). In response to the same 10 nM fMLP stimulation, <italic>plcg2<sup>kd</sup>
</italic> cells displayed a continuous, persistent translocation of F-tractin-GFP and colocalized with the PM marker on the plasma membrane (<xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5A</bold>
</xref>, lower panel, <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Video S10</bold>
</xref>). Using the same quantification method as in <xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4B</bold>
</xref>, we further quantified the actin polarization of CTL and <italic>plcg2<sup>kd</sup>
</italic> cells by the membrane translocation of F-tractin-GFP and confirmed that <italic>plcg2<sup>kd</sup>
</italic> cells display elevated and prolonged actin polymerization compared to CTL cells (<xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5B</bold>
</xref>). We further determined the actin polymerization of both CTL and <italic>plcg2<sup>kd</sup>
</italic> cells to 0.1 nM fMLP stimulation. In response to 0.1-nM fMLP stimulation, most CTL cells (&#x223c;90%) did not show the clear membrane translocation of F-tractin&#x2013;GFP to the PM, while they showed cortex localization of F-tractin and PM marker (<xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5C</bold>
</xref>, upper panel, <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Video S11</bold>
</xref>). In contrast, more than 80% of <italic>plcg2<sup>kd</sup>
</italic> cells showed the clear membrane translocation of F-tractin-GFP upon 0.1 nM fMLP stimulation (<xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5C</bold>
</xref>, lower panel, <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Video S11</bold>
</xref>). Quantitative measurement of membrane translocation of F-tractin in CTL and <italic>plcg2<sup>kd</sup>
</italic> cells shows a normal oscillation of actin polymerization in CTL cells, while a clear actin polymerization in <italic>plcg2<sup>kd</sup>
</italic> cells upon 0.1 nM fMLP stimulation (<xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5D</bold>
</xref>). Together, these results demonstrate that <italic>plcg2kd</italic> cells are capable of initiating actin polymerization in response to chemoattractant stimulation at subsensitive concentrations and exhibit prolonged, elevated actin assembly in response to low-dose chemoattractant stimulation.</p>
<fig id="f5" position="float">
<label>Figure&#xa0;5</label>
<caption>
<p>Increased actin polymerization in <italic>plcg2<sup>kd</sup>
</italic> cells in response to fMLP stimulation at a low (10 nM) or a subsensitive (0.1 nM) concentration. <bold>(A)</bold> Montage shows the membrane translocation of the F-actin probe (GFP-tagged F-tractin) in CTL and <italic>plcg2<sup>kd</sup>
</italic> cells upon fMLP stimulation at 10 nM. Cells expressing F-tractin GFP (green) and a PM marker (red) were stimulated with fMLP at time 0 s. Scale bar = 10 &#x3bc;m. Arrows indicate the localization of F-tractin before or after stimulation. See <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Video S10</bold>
</xref> (CTL, upper panel; <italic>plcg2<sup>kd</sup>
</italic>, lower panel) for a complete set of cell responses upon 10 nM fMLP stimulation. <bold>(B)</bold> Quantitative measurement of actin polymerization by the membrane translocation of Ftractin-GFP in CTL and <italic>plcg2<sup>kd</sup>
</italic> cells in response to fMLP stimulation. Mean &#xb1; SD is shown; n = 3 or 5 for CTL or <italic>plcg2<sup>kd</sup>
</italic> cells, respectively. <bold>(C)</bold> Montage shows the membrane translocation of the F-actin probe (GFP-tagged F-tractin) in CTL and <italic>plcg2<sup>kd</sup>
</italic> cells upon fMLP stimulation at 0.1 nM. Cells expressing F-tractin GFP (green) and a PM marker (red) were stimulated with fMLP at time 0 s. Scale bar = 10 &#x3bc;m. Arrows indicate the localization of F-tractin before or after stimulation. See <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Video S11</bold>
</xref> (CTL, upper panel; <italic>plcg2<sup>kd</sup>
</italic>, lower panel) for a complete set of cell responses upon 0.1 nM fMLP stimulation. <bold>(D)</bold> Quantitative measurement of actin polymerization by the membrane translocation of Ftractin-GFP in CTL and <italic>plcg2<sup>kd</sup>
</italic> cells in response to 0.1 nM fMLP stimulation. Mean &#xb1; SD is shown; n = 3 or 5 for CTL or <italic>plcg2<sup>kd</sup>
</italic> cells, respectively.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-16-1633390-g005.tif">
<alt-text content-type="machine-generated">Panel A shows time-lapse images of F-tractin and PM fluorescence in green and red respectively for CTL and plcg2 knockdown cells at 10 nanomolar. Panel B is a graph depicting F-tractin translocation over time for CTL and plcg2 knockdown at 10 nanomolar. Panel C presents similar time-lapse images at 0.1 nanomolar. Panel D displays a graph of F-tractin translocation at 0.1 nanomolar for the same conditions. White arrows in images highlight relevant cellular structures.</alt-text>
</graphic>
</fig>
</sec>
<sec id="s3_6">
<title>
<italic>plcg2<sup>kd</sup>
</italic> neutrophils chemotax in chemoattractant gradients at subsensitive concentrations</title>
<p>We found that <italic>capri<sup>kd</sup>
</italic> neutrophils, which lack Ras inhibitor CAPRI, display an increased sensitivity and elevated activation of Ras and its downstream effectors (<xref ref-type="bibr" rid="B23">23</xref>). More importantly, <italic>capri<sup>kd</sup>
</italic> neutrophils display an altered chemotaxis behavior: an improved chemotaxis in the gradients at subsensitive concentrations, a normal chemotaxis in the gradients at medium concentrations, and an impaired chemotaxis in the gradients at saturating concentrations. That is, neutrophils lacking CAPRI display an upshift in concentration range for chemotaxis (<xref ref-type="bibr" rid="B30">30</xref>). We have previously shown an impaired chemotaxis of <italic>plcg2<sup>kd</sup>
</italic> cells upon chemoattractant gradients at a saturating concentration (<xref ref-type="bibr" rid="B20">20</xref>). Next, we examined the chemotaxis behavior of CTL and <italic>plcg2<sup>kd</sup>
</italic> cells in the gradients of three chemoattractants at either medium (100 nM) or subsensitive (0.1 nM) concentrations (<xref ref-type="fig" rid="f6">
<bold>Figure&#xa0;6</bold>
</xref>, <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Video S12</bold>
</xref>). In the absence of a gradient, <italic>plcg2kd</italic> cells appeared to exhibit a broader random walk compared to CTL cells, although the difference was not statistically significant (<xref ref-type="fig" rid="f6">
<bold>Figures&#xa0;6A, B</bold>
</xref>). When exposed to gradients generated from a source at medium concentrations (100 nM), CTL and <italic>plcg2<sup>kd</sup>
</italic> cells displayed overall similar chemotaxis capability, although <italic>plcg2<sup>kd</sup>
</italic> cells displayed slightly decreased speed and total path length (<xref ref-type="fig" rid="f6">
<bold>Figure&#xa0;6B</bold>
</xref>). In the gradients generated from the sources of 0.1 nM, most CTL cells displayed random migration, while most <italic>plcg2<sup>kd</sup>
</italic> cells displayed a clear directed cell migration along the direction of the gradient. In conclusion, <italic>plcg2<sup>kd</sup>
</italic> cells display a concentration-dependent, altered chemotaxis behavior: an improved chemotaxis in the gradients at a subsensitive concentration, while a normal chemotaxis in the gradients at medium concentrations. Combined with the previous report (<xref ref-type="bibr" rid="B20">20</xref>), our results demonstrate that neutrophils lacking PLC&#x3b3;2 display an upshift of the concentration ranges of diverse chemoattractants for an efficient chemotaxis.</p>
<fig id="f6" position="float">
<label>Figure&#xa0;6</label>
<caption>
<p>
<italic>plcg2<sup>kd</sup>
</italic> neutrophils display improved chemotaxis in chemoattractant gradients at subsensitive concentrations. <bold>(A)</bold> Montages show the travel path of chemotaxing CTL or <italic>plcg2<sup>kd</sup>
</italic> cells in response to subsensitive or mid-concentration gradients. The plain or shaded panels on the left side of the images in the montage indicate either no gradient (NG) or chemoattractant gradients of fMLP (top), SDF1a (middle), or LTB4 (bottom) sourced from the indicated concentrations. The concentration on the top side of the terrace is 0 and the concentration at the bottom side of the terrace is as indicated on the left side of the terrace. Movement of at least 30 cells in each group was analyzed by DIAS software and is shown. See <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Video S12</bold>
</xref> (CTL, left, and <italic>plcg2<sup>kd</sup>
</italic>, right) for a complete set of ez-taxiscan images with the same conditions of chemoattractant concentrations shown in <bold>A. (B)</bold> Chemotaxis behaviors measured from A are described as four parameters: directionality, which is &#x201c;upward&#x201d; directionality, where 0 represents random movement and 1 represents straight movement toward the gradient; speed, defined as the distance that the centroid of the cell moves as a function of time; total path length, the total distance the cell has traveled; and roundness (%) for polarization, which is calculated as the ratio of the width to the length of the cell. Thus, a circle (no polarization) is 1, and a line (perfect polarization) is 0. Thirty cells from each group were measured for 10 min. Mean &#xb1; SD are shown. A student&#x2019;s <italic>t</italic>-test was used to calculate the <italic>p</italic>-values. Statistical significance is indicated as follows: <italic>ns</italic> (not significant <italic>p</italic> &gt; 0.05), *(<italic>p</italic> &lt; 0.0.05), **(<italic>p</italic> &lt; 0.01), ***(<italic>p</italic> &lt; 0.001), or ****(<italic>p</italic> &lt; 0.0001).</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-16-1633390-g006.tif">
<alt-text content-type="machine-generated">Panel A shows tracks of migrating cells under different conditions for CTL and plcg2kd groups with varying concentrations of fMLP, SDF1&#x3b1;, and LTB4, highlighted in green. Panel B displays graphs comparing total path length, speed, directionality, and roundness of cells under the same conditions. Statistical significance is denoted by asterisks.</alt-text>
</graphic>
</fig>
</sec>
</sec>
<sec id="s4" sec-type="discussion">
<title>Discussion</title>
<p>Chemoattractant-triggered PLC&#x3b2;2/&#x3b2;3 activation and the essential role of PLC&#x3b2;2/&#x3b2;3 in subsequent calcium signaling in neutrophils have been previously characterized (<xref ref-type="bibr" rid="B2">2</xref>). However, no connection has been made between calcium oscillation and cell sensitivity toward chemoattractants. The mediator(s) or biological functions of calcium oscillation in neutrophils largely remain elusive. In the present study, we show that PLC&#x3b3;2-mediated spontaneous calcium oscillation controls the basal Ras activity and neutrophil sensitivity by the recruitment of CAPRI to the plasma membrane. More importantly, the chemoattractant-induced PLC&#x3b3;2 activation constitutes the essential calcium response for the PM recruitment of CAPRI and subsequent adaptation of Ras and downstream effectors for proper chemotaxis. Hence, by applying the above two mechanisms, PLC&#x3b3;2 gates the chemoattractant concentration range for neutrophil chemotaxis (<xref ref-type="fig" rid="f7">
<bold>Figure&#xa0;7</bold>
</xref>).</p>
<fig id="f7" position="float">
<label>Figure&#xa0;7</label>
<caption>
<p>A schematic illustration of the dual roles of PLC&#x3b3;2 in controlling cell sensitivity and GPCR-mediated chemotaxis.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-16-1633390-g007.tif">
<alt-text content-type="machine-generated">Flowchart titled &#x201c;Dual roles of PLC&#x3b3;2&#x201d; depicting two pathways. The left pathway starts from &#x201c;Resting state&#x201d; to &#x201c;Active Rac1,&#x201d; leading to &#x201c;PLC&#x3b3;2,&#x201d; then &#x201c;Spontaneous calcium oscillation,&#x201d; followed by &#x201c;CAPRI,&#x201d; &#x201c;Basal Ras activity,&#x201d; and ends with &#x201c;Sensitivity.&#x201d; The right pathway begins with &#x201c;Chemoattractant stimulation,&#x201d; &#x201c;PLC&#x3b2;3/&#x3b2;3,&#x201d; then &#x201c;Initiate calcium response,&#x201d; continues to &#x201c;PLC&#x3b3;2,&#x201d; &#x201c;Sustain calcium response,&#x201d; &#x201c;CAPRI,&#x201d; &#x201c;Ras adaptation,&#x201d; and concludes with &#x201c;Chemotaxis."</alt-text>
</graphic>
</fig>
<p>Calcium oscillation is ubiquitous, triggered either spontaneously or upon receptor-ligand binding in all cells. The PLC-derived, IP<sub>3</sub>-mediated intracellular Ca<sup>2+</sup> release triggers the initial [Ca<sup>2+</sup>] increase and constitutes calcium oscillation and calcium influx, which includes the entry of Ca<sup>2+</sup> through the activation of store-operated channels (SOCs) in the plasma membrane. Murine PLC&#x3b2;2/&#x3b2;3-deficient (<italic>plcb2<sup>-/-</sup>b3<sup>-/-</sup>
</italic>) neutrophils display a significant decrease in IP<sub>3</sub> production and calcium response, demonstrating the essential role of PLC&#x3b2;2/&#x3b2;3 in chemoattractant-mediated calcium response (<xref ref-type="bibr" rid="B2">2</xref>). However, mammalian neutrophils express three main isoforms of PLC, including -&#x3b2;2, -&#x3b2;3, and -&#x3b3;2 (<xref ref-type="bibr" rid="B15">15</xref>). We previously reported that chemoattractant stimulation induces robust plasma membrane translocation of PLC&#x3b3;2 (<xref ref-type="bibr" rid="B17">17</xref>), which is a highly expressed PLC isoform that can be activated by membrane translocation (<xref ref-type="bibr" rid="B18">18</xref>, <xref ref-type="bibr" rid="B19">19</xref>). We also found that the membrane translocation of PLC&#x3b3;2 requires its C2-domain (<xref ref-type="bibr" rid="B20">20</xref>). To delineate the contribution of PLC&#x3b2;2/&#x3b2;3 and &#x3b3;2 in chemoattractant-induced calcium signaling, we monitored calcium response in <italic>plcg2<sup>kd</sup>
</italic> cells, which express endogenous PLC&#x3b2;2/&#x3b2;3. In these cells, the chemoattractant stimulation-triggered calcium response results from the activation of PLC&#x3b2;2/&#x3b2;3. The observed difference between CTL and <italic>plcg2<sup>kd</sup>
</italic> cells is the contribution of PLC&#x3b3;2 in this process. <italic>plcg2<sup>kd</sup>
</italic> neutrophils display a concentration-dependent calcium response: in response to stimuli at a saturating dose, <italic>plcg2<sup>kd</sup>
</italic> neutrophils display calcium responses with a normal amplitude, but with significantly decreased duration or secondary (oscillatory) calcium response (<xref ref-type="bibr" rid="B20">20</xref>); upon medium (10 nM fMLP) or low (1 nM fMLP) stimuli, <italic>plcg2<sup>kd</sup>
</italic> neutrophils display significantly reduced calcium response in both amplitude and duration; upon subsensitive stimuli, <italic>plcg2<sup>kd</sup>
</italic> neutrophils do not display spontaneous calcium oscillation (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1</bold>
</xref>). Taken together, the above results indicate that PLC&#x3b2;2/&#x3b2;3 is responsible for the initial calcium response upon chemoattractant stimulation, and PLC&#x3b3;2 is responsible for sustaining the calcium response and mediating the spontaneous calcium oscillation.</p>
<p>Few connections have been made between calcium oscillation and cell sensitivity to extracellular stimuli. No clear biological function of calcium oscillation had been implicated in chemotaxis of neutrophils. In both the model organism <italic>Dictyostelium</italic> and mammalian neutrophils, Ras plays a central role in the signaling pathways of chemotaxis of eukaryotic cells and serves as a hallmark of basal cell sensitivity. Cells lacking negative regulators of Ras signaling, such as <italic>c2gapA<sup>-</sup> Dictyostelium</italic> cells or <italic>capri<sup>kd</sup>
</italic> neutrophils, often display an increased basal Ras activity and cell migration, and hypersensitivity to stimuli (<xref ref-type="bibr" rid="B30">30</xref>). The consequence is an upshift in the concentration range of chemoattractant gradients, in which cells can sense and chemotax. Specifically, these cells are able to sense and chemotax in gradient at subsensitive concentrations but fail to migrate effectively in the gradients at saturating concentrations. Plasma membrane (PM) targeting of these Ras GAPs is required for their functions and often depends on calcium signaling. In neutrophils, we found that the recruitment of CAPRI to PM is significant reduced in <italic>plcg2<sup>kd</sup>
</italic> neutrophils in both resting and chemoattractant-stimulated conditions (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2</bold>
</xref>) (<xref ref-type="bibr" rid="B20">20</xref>). Similar to <italic>capri<sup>kd</sup>
</italic> neutrophils, <italic>plcg2<sup>kd</sup>
</italic> neutrophils also display an increased Ras activity, sensitivity, and an upshift in the concentration range of chemoattractant gradients (<xref ref-type="fig" rid="f2">
<bold>Figures&#xa0;2</bold>
</xref>&#x2013;<xref ref-type="fig" rid="f6">
<bold>6</bold>
</xref>) (<xref ref-type="bibr" rid="B20">20</xref>). Additionally, <italic>plcg2<sup>kd</sup>
</italic> cells show slightly increased random migration, although we did not quantify chemokinesis in this context. Our result reveals a molecular mechanism by which neutrophils use PLC&#x3b3;2-mediated spontaneous calcium oscillation to regulate cellular sensitivity to external stimuli. Moreover, PLC&#x3b3;2-dependent calcium signaling is required to recruit CAPRI to the PM for Ras deactivation, enabling proper Ras adaptation (<xref ref-type="bibr" rid="B20">20</xref>). In conclusion, PLC&#x3b3;2 serves as a critical regulator that gates the effective concentration range for neutrophil chemotaxis.</p>
<p>Although clinical reports on neutrophil function in patients with PLC&#x3b3;2 deficiency are sparse, studies in <italic>plc&#x3b3;2<sup>-/-</sup>
</italic> mouse models offer translational relevance. In the brain, PLC&#x3b3;2 is primarily expressed by microglia and loss of PLC&#x3b3;2 function has subtle effects on brain homeostasis that may underlie enhanced vulnerability to AD pathology via microglia and myelin dysfunction (<xref ref-type="bibr" rid="B11">11</xref>). Two independent studies have reported that <italic>plc&#x3b3;2<sup>-/-</sup>
</italic> mice are protected from developing arthritis, suggeting a pro-inflammatory role for PLC&#x3b3;2 in this context (<xref ref-type="bibr" rid="B16">16</xref>, <xref ref-type="bibr" rid="B31">31</xref>). Consistent with our findings in HL60, <italic>plc&#x3b3;2<sup>-/-</sup>
</italic> mouse neutrophils exhibit improved chemotaxis in gradients generated from 100 nM fMLP, but impaired chemotaxis in gradients from a 300 nM fMLP source (<xref ref-type="bibr" rid="B16">16</xref>). Similarly, these two reports show that <italic>plc&#x3b3;2<sup>-/-</sup>
</italic> mouse neutrophils display increased cell migration, improved chemotaxis, compared to wild-type counterparts in <italic>in vitro</italic> chemotaxis assays done with chemoattractants at low concentration assay or <italic>in vivo</italic> chemotaxis assays (<xref ref-type="bibr" rid="B16">16</xref>, <xref ref-type="bibr" rid="B31">31</xref>). These findings are particularly relevant given that circulating and tissue-local chemoattractant concentrations in physiological and inflammatory contexts are often low (<xref ref-type="bibr" rid="B32">32</xref>&#x2013;<xref ref-type="bibr" rid="B34">34</xref>). In agreement with these observations, we found that <italic>plcg2<sup>kd</sup>
</italic> human neutrophil-like cells display concentration-dependent chemotaxis: they show improved chemotaxis in gradients of multiple chemoattractants at low or subsensitive concentrations, but impaired chemotaxis in gradients at saturating concentrations (<xref ref-type="fig" rid="f6">
<bold>Figure&#xa0;6</bold>
</xref>) (<xref ref-type="bibr" rid="B20">20</xref>). This suggests a conserved role of PLC&#x3b3;2 in modulating neutrophil sensitivity and chemoattractant concentration-range detection. Future work using primary human neutrophils or patient-derived samples will be essential to validate these mechanisms and further understand their relevance to immune regulation and disease pathogenesis.</p>
</sec>
</body>
<back>
<sec id="s5" sec-type="data-availability">
<title>Data availability statement</title>
<p>The original contributions presented in the study are included in the article/<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Material</bold>
</xref>. Further inquiries can be directed to the corresponding author.</p>
</sec>
<sec id="s6" sec-type="ethics-statement">
<title>Ethics statement</title>
<p>Ethical approval was not required for the studies on humans in accordance with the local legislation and institutional requirements because only commercially available established cell lines were used.</p>
</sec>
<sec id="s7" sec-type="author-contributions">
<title>Author contributions</title>
<p>XX: Conceptualization, Data curation, Formal Analysis, Investigation, Methodology, Project administration, Resources, Software, Supervision, Validation, Visualization, Writing &#x2013; original draft, Writing &#x2013; review &amp; editing. WK: Data curation, Formal Analysis, Investigation, Writing &#x2013; review &amp; editing. AL: Formal Analysis, Writing &#x2013; review &amp; editing. TJ: Funding acquisition, Writing &#x2013; review &amp; editing.</p>
</sec>
<sec id="s8" sec-type="funding-information">
<title>Funding</title>
<p>The author(s) declare that financial support was received for the research and/or publication of this article. This work was supported by DIR, NIAID (National Institute of Allergy and Infectious Diseases), NIH (National Institutes of Health).</p>
</sec>
<sec id="s9" sec-type="COI-statement">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="s10" sec-type="ai-statement">
<title>Generative AI statement</title>
<p>The author(s) declare that no Generative AI was used in the creation of this manuscript.</p>
</sec>
<sec id="s11" sec-type="disclaimer">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<sec id="s12" sec-type="supplementary-material">
<title>Supplementary material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fimmu.2025.1633390/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fimmu.2025.1633390/full#supplementary-material</ext-link>
</p>
<supplementary-material xlink:href="DataSheet1.pdf" id="SF1" mimetype="application/pdf"/>
<supplementary-material xlink:href="Video1.avi" id="SM1" mimetype="video/x-msvideo"/>
<supplementary-material xlink:href="Video2.avi" id="SM2" mimetype="video/x-msvideo"/>
<supplementary-material xlink:href="Video3.avi" id="SM3" mimetype="video/x-msvideo"/>
<supplementary-material xlink:href="Video4.avi" id="SM4" mimetype="video/x-msvideo"/>
<supplementary-material xlink:href="Video5.avi" id="SM5" mimetype="video/x-msvideo"/>
<supplementary-material xlink:href="Video6.avi" id="SM6" mimetype="video/x-msvideo"/>
<supplementary-material xlink:href="Video7.avi" id="SM7" mimetype="video/x-msvideo"/>
<supplementary-material xlink:href="Video8.avi" id="SM8" mimetype="video/x-msvideo"/>
<supplementary-material xlink:href="Video9.avi" id="SM9" mimetype="video/x-msvideo"/>
<supplementary-material xlink:href="Video10.avi" id="SM10" mimetype="video/x-msvideo"/>
<supplementary-material xlink:href="Video11.avi" id="SM11" mimetype="video/x-msvideo"/>
<supplementary-material xlink:href="Video12.avi" id="SM12" mimetype="video/x-msvideo"/>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<label>1</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Petty</surname> <given-names>HR</given-names>
</name>
</person-group>. <article-title>Neutrophil oscillations: temporal and spatiotemporal aspects of cell behavior</article-title>. <source>Immunol Res</source>. (<year>2001</year>) <volume>23</volume>:<fpage>85</fpage>&#x2013;<lpage>94</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1385/IR:23:1:85</pub-id>, PMID: <pub-id pub-id-type="pmid">11417862</pub-id></citation></ref>
<ref id="B2">
<label>2</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Jiang</surname> <given-names>H</given-names>
</name>
<name>
<surname>Xie</surname> <given-names>W</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Smrcka</surname> <given-names>AV</given-names>
</name>
<name>
<surname>Wu</surname> <given-names>D</given-names>
</name>
</person-group>. <article-title>Roles of PLC-beta2 and -beta3 and PI3Kgamma in chemoattractant-mediated signal transduction</article-title>. <source>Science</source>. (<year>2000</year>) <volume>287</volume>:<page-range>1046&#x2013;9</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1126/science.287.5455.1046</pub-id>, PMID: <pub-id pub-id-type="pmid">10669417</pub-id></citation></ref>
<ref id="B3">
<label>3</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tang</surname> <given-names>W</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Xu</surname> <given-names>W</given-names>
</name>
<name>
<surname>Harden</surname> <given-names>TK</given-names>
</name>
<name>
<surname>Sondek</surname> <given-names>J</given-names>
</name>
<name>
<surname>Sun</surname> <given-names>L</given-names>
</name>
<etal/>
</person-group>. <article-title>A PLCbeta/PI3Kgamma-GSK3 signaling pathway regulates cofilin phosphatase slingshot2 and neutrophil polarization and chemotaxis</article-title>. <source>Dev Cell</source>. (<year>2011</year>) <volume>21</volume>:<page-range>1038&#x2013;50</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.devcel.2011.10.023</pub-id>, PMID: <pub-id pub-id-type="pmid">22172670</pub-id></citation></ref>
<ref id="B4">
<label>4</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tsai</surname> <given-names>FC</given-names>
</name>
<name>
<surname>Meyer</surname> <given-names>T</given-names>
</name>
</person-group>. <article-title>Ca2+ pulses control local cycles of lamellipodia retraction and adhesion along the front of migrating cells</article-title>. <source>Curr Biol</source>. (<year>2012</year>) <volume>22</volume>:<page-range>837&#x2013;42</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.cub.2012.03.037</pub-id>, PMID: <pub-id pub-id-type="pmid">22521790</pub-id></citation></ref>
<ref id="B5">
<label>5</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Clark</surname> <given-names>AJ</given-names>
</name>
<name>
<surname>Romero</surname> <given-names>R</given-names>
</name>
<name>
<surname>Petty</surname> <given-names>HR</given-names>
</name>
</person-group>. <article-title>Improved detection of nicotinamide adenine dinucleotide phosphate oscillations within human neutrophils</article-title>. <source>Cytometry A</source>. (<year>2010</year>) <volume>77</volume>:<page-range>976&#x2013;82</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/cyto.a.20961</pub-id>, PMID: <pub-id pub-id-type="pmid">21290472</pub-id></citation></ref>
<ref id="B6">
<label>6</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Koss</surname> <given-names>H</given-names>
</name>
<name>
<surname>Bunney</surname> <given-names>TD</given-names>
</name>
<name>
<surname>Behjati</surname> <given-names>S</given-names>
</name>
<name>
<surname>Katan</surname> <given-names>M</given-names>
</name>
</person-group>. <article-title>Dysfunction of phospholipase Cgamma in immune disorders and cancer</article-title>. <source>Trends Biochem Sci</source>. (<year>2014</year>) <volume>39</volume>:<page-range>603&#x2013;11</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.tibs.2014.09.004</pub-id>, PMID: <pub-id pub-id-type="pmid">25456276</pub-id></citation></ref>
<ref id="B7">
<label>7</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ombrello</surname> <given-names>MJ</given-names>
</name>
<name>
<surname>Remmers</surname> <given-names>EF</given-names>
</name>
<name>
<surname>Sun</surname> <given-names>G</given-names>
</name>
<name>
<surname>Freeman</surname> <given-names>AF</given-names>
</name>
<name>
<surname>Datta</surname> <given-names>S</given-names>
</name>
<name>
<surname>Torabi-Parizi</surname> <given-names>P</given-names>
</name>
<etal/>
</person-group>. <article-title>Cold urticaria, immunodeficiency, and autoimmunity related to PLCG2 deletions</article-title>. <source>N Engl J Med</source>. (<year>2012</year>) <volume>366</volume>:<page-range>330&#x2013;8</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1056/NEJMoa1102140</pub-id>, PMID: <pub-id pub-id-type="pmid">22236196</pub-id></citation></ref>
<ref id="B8">
<label>8</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Caraux</surname> <given-names>A</given-names>
</name>
<name>
<surname>Kim</surname> <given-names>N</given-names>
</name>
<name>
<surname>Bell</surname> <given-names>SE</given-names>
</name>
<name>
<surname>Zompi</surname> <given-names>S</given-names>
</name>
<name>
<surname>Ranson</surname> <given-names>T</given-names>
</name>
<name>
<surname>Lesjean-Pottier</surname> <given-names>S</given-names>
</name>
<etal/>
</person-group>. <article-title>Phospholipase C-&#x3b3;2 is essential for NK cell cytotoxicity and innate immunity to Malignant and virally infected cells</article-title>. <source>Blood</source>. (<year>2006</year>) <volume>107</volume>:<fpage>994</fpage>&#x2013;<lpage>1002</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1182/blood-2005-06-2428</pub-id>, PMID: <pub-id pub-id-type="pmid">16204312</pub-id></citation></ref>
<ref id="B9">
<label>9</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jing</surname> <given-names>H</given-names>
</name>
<name>
<surname>Reed</surname> <given-names>A</given-names>
</name>
<name>
<surname>Ulanovskaya</surname> <given-names>OA</given-names>
</name>
<name>
<surname>Grigoleit</surname> <given-names>J-S</given-names>
</name>
<name>
<surname>Herbst</surname> <given-names>DM</given-names>
</name>
<name>
<surname>Henry</surname> <given-names>CL</given-names>
</name>
<etal/>
</person-group>. <article-title>Phospholipase C&#x3b3;2 regulates endocannabinoid and eicosanoid networks in innate immune cells</article-title>. <source>Proc Natl Acad Sci</source>. (<year>2021</year>) <volume>118</volume>:<elocation-id>e2112971118</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1073/pnas.2112971118</pub-id>, PMID: <pub-id pub-id-type="pmid">34607960</pub-id></citation></ref>
<ref id="B10">
<label>10</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Obst</surname> <given-names>J</given-names>
</name>
<name>
<surname>Hall-Roberts</surname> <given-names>HL</given-names>
</name>
<name>
<surname>Smith</surname> <given-names>TB</given-names>
</name>
<name>
<surname>Kreuzer</surname> <given-names>M</given-names>
</name>
<name>
<surname>Magno</surname> <given-names>L</given-names>
</name>
<name>
<surname>Di Daniel</surname> <given-names>E</given-names>
</name>
<etal/>
</person-group>. <article-title>PLC&#x3b3;2 regulates TREM2 signalling and integrin-mediated adhesion and migration of human iPSC-derived macrophages</article-title>. <source>Sci Rep</source>. (<year>2021</year>) <volume>11</volume>:<fpage>19842</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41598-021-96144-7</pub-id>, PMID: <pub-id pub-id-type="pmid">34615897</pub-id></citation></ref>
<ref id="B11">
<label>11</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Palavicini</surname> <given-names>JP</given-names>
</name>
<name>
<surname>Miller</surname> <given-names>HE</given-names>
</name>
<name>
<surname>Smith</surname> <given-names>S</given-names>
</name>
<name>
<surname>Campos</surname> <given-names>G</given-names>
</name>
<name>
<surname>Hopp</surname> <given-names>SC</given-names>
</name>
</person-group>. <article-title>Multi-omics analyses reveal unexpected effects of PLCg2 deficiency in the brain</article-title>. <source>Alzheimer&#x2019;s Dementia</source>. (<year>2022</year>) <volume>18</volume>:<elocation-id>e069302</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/alz.069302</pub-id>
</citation></ref>
<ref id="B12">
<label>12</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Behjati</surname> <given-names>S</given-names>
</name>
<name>
<surname>Tarpey</surname> <given-names>PS</given-names>
</name>
<name>
<surname>Sheldon</surname> <given-names>H</given-names>
</name>
<name>
<surname>Martincorena</surname> <given-names>I</given-names>
</name>
<name>
<surname>Van Loo</surname> <given-names>P</given-names>
</name>
<name>
<surname>Gundem</surname> <given-names>G</given-names>
</name>
<etal/>
</person-group>. <article-title>Recurrent PTPRB and PLCG1 mutations in angiosarcoma</article-title>. <source>Nat Genet</source>. (<year>2014</year>) <volume>46</volume>:<page-range>376&#x2013;9</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/ng.2921</pub-id>, PMID: <pub-id pub-id-type="pmid">24633157</pub-id></citation></ref>
<ref id="B13">
<label>13</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Danielsen</surname> <given-names>SA</given-names>
</name>
<name>
<surname>Cekaite</surname> <given-names>L</given-names>
</name>
<name>
<surname>Agesen</surname> <given-names>TH</given-names>
</name>
<name>
<surname>Sveen</surname> <given-names>A</given-names>
</name>
<name>
<surname>Nesbakken</surname> <given-names>A</given-names>
</name>
<name>
<surname>Thiis-Evensen</surname> <given-names>E</given-names>
</name>
<etal/>
</person-group>. <article-title>Phospholipase C isozymes are deregulated in colorectal cancer&#x2013;insights gained from gene set enrichment analysis of the transcriptome</article-title>. <source>PloS One</source>. (<year>2011</year>) <volume>6</volume>:<elocation-id>e24419</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1371/journal.pone.0024419</pub-id>, PMID: <pub-id pub-id-type="pmid">21909432</pub-id></citation></ref>
<ref id="B14">
<label>14</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Martins</surname> <given-names>M</given-names>
</name>
<name>
<surname>McCarthy</surname> <given-names>A</given-names>
</name>
<name>
<surname>Baxendale</surname> <given-names>R</given-names>
</name>
<name>
<surname>Guichard</surname> <given-names>S</given-names>
</name>
<name>
<surname>Magno</surname> <given-names>L</given-names>
</name>
<name>
<surname>Kessaris</surname> <given-names>N</given-names>
</name>
<etal/>
</person-group>. <article-title>Tumor suppressor role of phospholipase C epsilon in Ras-triggered cancers</article-title>. <source>Proc Natl Acad Sci U S A</source>. (<year>2014</year>) <volume>111</volume>:<page-range>4239&#x2013;44</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1073/pnas.1311500111</pub-id>, PMID: <pub-id pub-id-type="pmid">24591640</pub-id></citation></ref>
<ref id="B15">
<label>15</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Suh</surname> <given-names>PG</given-names>
</name>
<name>
<surname>Park</surname> <given-names>JI</given-names>
</name>
<name>
<surname>Manzoli</surname> <given-names>L</given-names>
</name>
<name>
<surname>Cocco</surname> <given-names>L</given-names>
</name>
<name>
<surname>Peak</surname> <given-names>JC</given-names>
</name>
<name>
<surname>Katan</surname> <given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>Multiple roles of phosphoinositide-specific phospholipase C isozymes</article-title>. <source>BMB Rep</source>. (<year>2008</year>) <volume>41</volume>:<page-range>415&#x2013;34</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.5483/BMBRep.2008.41.6.415</pub-id>, PMID: <pub-id pub-id-type="pmid">18593525</pub-id></citation></ref>
<ref id="B16">
<label>16</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jakus</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Simon</surname> <given-names>E</given-names>
</name>
<name>
<surname>Frommhold</surname> <given-names>D</given-names>
</name>
<name>
<surname>Sperandio</surname> <given-names>M</given-names>
</name>
<name>
<surname>M&#xf3;csai</surname> <given-names>A</given-names>
</name>
</person-group>. <article-title>Critical role of phospholipase C&#x3b3;2 in integrin and Fc receptor-mediated neutrophil functions and the effector phase of autoimmune arthritis</article-title>. <source>J Exp Med</source>. (<year>2009</year>) <volume>206</volume>:<page-range>577&#x2013;93</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1084/jem.20081859</pub-id>, PMID: <pub-id pub-id-type="pmid">19273622</pub-id></citation></ref>
<ref id="B17">
<label>17</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xu</surname> <given-names>X</given-names>
</name>
<name>
<surname>Gera</surname> <given-names>N</given-names>
</name>
<name>
<surname>Li</surname> <given-names>H</given-names>
</name>
<name>
<surname>Yun</surname> <given-names>M</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>L</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>Y</given-names>
</name>
<etal/>
</person-group>. <article-title>GPCR-mediated PLC&#x3b2;&#x3b3;/PKC&#x3b2;/PKD signaling pathway regulates the cofilin phosphatase slingshot 2 in neutrophil chemotaxis</article-title>. <source>Mol Biol Cell</source>. (<year>2015</year>) <volume>26</volume>:<page-range>874&#x2013;86</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1091/mbc.E14-05-0982</pub-id>, PMID: <pub-id pub-id-type="pmid">25568344</pub-id></citation></ref>
<ref id="B18">
<label>18</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Falasca</surname> <given-names>M</given-names>
</name>
<name>
<surname>Logan</surname> <given-names>SK</given-names>
</name>
<name>
<surname>Lehto</surname> <given-names>VP</given-names>
</name>
<name>
<surname>Baccante</surname> <given-names>G</given-names>
</name>
<name>
<surname>Lemmon</surname> <given-names>MA</given-names>
</name>
<name>
<surname>Schlessinger</surname> <given-names>J</given-names>
</name>
</person-group>. <article-title>Activation of phospholipase C gamma by PI 3-kinase-induced PH domain-mediated membrane targeting</article-title>. <source>EMBO J</source>. (<year>1998</year>) <volume>17</volume>:<page-range>414&#x2013;22</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/emboj/17.2.414</pub-id>, PMID: <pub-id pub-id-type="pmid">9430633</pub-id></citation></ref>
<ref id="B19">
<label>19</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nishida</surname> <given-names>M</given-names>
</name>
<name>
<surname>Sugimoto</surname> <given-names>K</given-names>
</name>
<name>
<surname>Hara</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Mori</surname> <given-names>E</given-names>
</name>
<name>
<surname>Morii</surname> <given-names>T</given-names>
</name>
<name>
<surname>Kurosaki</surname> <given-names>T</given-names>
</name>
<etal/>
</person-group>. <article-title>Amplification of receptor signalling by Ca2+ entry-mediated translocation and activation of PLCgamma2 in B lymphocytes</article-title>. <source>EMBO J</source>. (<year>2003</year>) <volume>22</volume>:<page-range>4677&#x2013;88</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/emboj/cdg457</pub-id>, PMID: <pub-id pub-id-type="pmid">12970180</pub-id></citation></ref>
<ref id="B20">
<label>20</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xu</surname> <given-names>X</given-names>
</name>
<name>
<surname>Wen</surname> <given-names>X</given-names>
</name>
<name>
<surname>Bhimani</surname> <given-names>S</given-names>
</name>
<name>
<surname>Moosa</surname> <given-names>A</given-names>
</name>
<name>
<surname>Parsons</surname> <given-names>D</given-names>
</name>
<name>
<surname>Ha</surname> <given-names>H</given-names>
</name>
<etal/>
</person-group>. <article-title>G protein-coupled receptor-mediated membrane targeting of PLC&#x3b3;2 is essential for neutrophil chemotaxis</article-title>. <source>J Leukoc Biol</source>. (<year>2023</year>) <volume>114</volume>:<page-range>126&#x2013;41</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/jleuko/qiad043</pub-id>, PMID: <pub-id pub-id-type="pmid">37040618</pub-id></citation></ref>
<ref id="B21">
<label>21</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nalefski</surname> <given-names>EA</given-names>
</name>
<name>
<surname>Falke</surname> <given-names>JJ</given-names>
</name>
</person-group>. <article-title>The C2 domain calcium-binding motif: Structural and functional diversity</article-title>. <source>Protein Science</source>. (<year>1996</year>) <volume>5</volume>:<page-range>2375&#x2013;90</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/pro.5560051201</pub-id>, PMID: <pub-id pub-id-type="pmid">8976547</pub-id></citation></ref>
<ref id="B22">
<label>22</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname> <given-names>Q</given-names>
</name>
<name>
<surname>Walker</surname> <given-names>SA</given-names>
</name>
<name>
<surname>Gao</surname> <given-names>D</given-names>
</name>
<name>
<surname>Taylor</surname> <given-names>JA</given-names>
</name>
<name>
<surname>Dai</surname> <given-names>YF</given-names>
</name>
<name>
<surname>Arkell</surname> <given-names>RS</given-names>
</name>
<etal/>
</person-group>. <article-title>CAPRI and RASAL impose different modes of information processing on Ras due to contrasting temporal filtering of Ca2+</article-title>. <source>J Cell Biol</source>. (<year>2005</year>) <volume>170</volume>:<page-range>183&#x2013;90</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1083/jcb.200504167</pub-id>, PMID: <pub-id pub-id-type="pmid">16009725</pub-id></citation></ref>
<ref id="B23">
<label>23</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xu</surname> <given-names>X</given-names>
</name>
<name>
<surname>Wen</surname> <given-names>X</given-names>
</name>
<name>
<surname>Moosa</surname> <given-names>A</given-names>
</name>
<name>
<surname>Bhimani</surname> <given-names>S</given-names>
</name>
<name>
<surname>Jin</surname> <given-names>T</given-names>
</name>
</person-group>. <article-title>Ras inhibitor CAPRI enables neutrophil-like cells to chemotax through a higher-concentration range of gradients</article-title>. <source>Proc Natl Acad Sci U S A</source>. (<year>2021</year>) <volume>118</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.1073/pnas.2002162118</pub-id>, PMID: <pub-id pub-id-type="pmid">34675073</pub-id></citation></ref>
<ref id="B24">
<label>24</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yi</surname> <given-names>J</given-names>
</name>
<name>
<surname>Wu</surname> <given-names>XS</given-names>
</name>
<name>
<surname>Crites</surname> <given-names>T</given-names>
</name>
<name>
<surname>Hammer</surname> <given-names>JA</given-names>
<suffix>3rd</suffix>
</name>
</person-group>. <article-title>Actin retrograde flow and actomyosin II arc contraction drive receptor cluster dynamics at the immunological synapse in Jurkat T cells</article-title>. <source>Mol Biol Cell</source>. (<year>2012</year>) <volume>23</volume>:<page-range>834&#x2013;52</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1091/mbc.e11-08-0731</pub-id>, PMID: <pub-id pub-id-type="pmid">22219382</pub-id></citation></ref>
<ref id="B25">
<label>25</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xu</surname> <given-names>X</given-names>
</name>
<name>
<surname>Yun</surname> <given-names>M</given-names>
</name>
<name>
<surname>Wen</surname> <given-names>X</given-names>
</name>
<name>
<surname>Brzostowski</surname> <given-names>J</given-names>
</name>
<name>
<surname>Quan</surname> <given-names>W</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>QJ</given-names>
</name>
<etal/>
</person-group>. <article-title>Quantitative monitoring spatiotemporal activation of ras and PKD1 using confocal fluorescent microscopy</article-title>. <source>Methods Mol Biol</source>. (<year>2016</year>) <volume>1407</volume>:<page-range>307&#x2013;23</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/978-1-4939-3480-5_22</pub-id>, PMID: <pub-id pub-id-type="pmid">27271911</pub-id></citation></ref>
<ref id="B26">
<label>26</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wen</surname> <given-names>X</given-names>
</name>
<name>
<surname>Jin</surname> <given-names>T</given-names>
</name>
<name>
<surname>Xu</surname> <given-names>X</given-names>
</name>
</person-group>. <article-title>Imaging G protein-coupled receptor-mediated chemotaxis and its signaling events in neutrophil-like HL60 cells</article-title>. <source>J Vis Exp</source>. (<year>2016</year>). doi:&#xa0;<pub-id pub-id-type="doi">10.3791/54511-v</pub-id>, PMID: <pub-id pub-id-type="pmid">27684322</pub-id></citation></ref>
<ref id="B27">
<label>27</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wessels</surname> <given-names>D</given-names>
</name>
<name>
<surname>Voss</surname> <given-names>E</given-names>
</name>
<name>
<surname>Von Bergen</surname> <given-names>N</given-names>
</name>
<name>
<surname>Burns</surname> <given-names>R</given-names>
</name>
<name>
<surname>Stites</surname> <given-names>J</given-names>
</name>
<name>
<surname>Soll</surname> <given-names>DR</given-names>
</name>
</person-group>. <article-title>A computer-assisted system for reconstructing and interpreting the dynamic three-dimensional relationships of the outer surface, nucleus and pseudopods of crawling cells</article-title>. <source>Cell Motil Cytoskeleton</source>. (<year>1998</year>) <volume>41</volume>:<page-range>225&#x2013;46</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/(SICI)1097-0169(1998)41:3&lt;225::AID-CM4&gt;3.0.CO;2-I</pub-id>, PMID: <pub-id pub-id-type="pmid">9829777</pub-id></citation></ref>
<ref id="B28">
<label>28</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Suire</surname> <given-names>S</given-names>
</name>
<name>
<surname>Condliffe</surname> <given-names>AM</given-names>
</name>
<name>
<surname>Ferguson</surname> <given-names>GJ</given-names>
</name>
<name>
<surname>Ellson</surname> <given-names>CD</given-names>
</name>
<name>
<surname>Guillou</surname> <given-names>H</given-names>
</name>
<name>
<surname>Davidson</surname> <given-names>K</given-names>
</name>
<etal/>
</person-group>. <article-title>Gbetagammas and the Ras binding domain of p110gamma are both important regulators of PI(3)Kgamma signalling in neutrophils</article-title>. <source>Nat Cell Biol</source>. (<year>2006</year>) <volume>8</volume>:<page-range>1303&#x2013;9</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/ncb1494</pub-id>, PMID: <pub-id pub-id-type="pmid">17041586</pub-id></citation></ref>
<ref id="B29">
<label>29</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Suire</surname> <given-names>S</given-names>
</name>
<name>
<surname>Lecureuil</surname> <given-names>C</given-names>
</name>
<name>
<surname>Anderson</surname> <given-names>KE</given-names>
</name>
<name>
<surname>Damoulakis</surname> <given-names>G</given-names>
</name>
<name>
<surname>Niewczas</surname> <given-names>I</given-names>
</name>
<name>
<surname>Davidson</surname> <given-names>K</given-names>
</name>
<etal/>
</person-group>. <article-title>GPCR activation of Ras and PI3Kc in neutrophils depends on PLCb2/b3 and the RasGEF RasGRP4</article-title>. <source>EMBO J</source>. (<year>2012</year>) <volume>31</volume>:<page-range>3118&#x2013;29</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/emboj.2012.167</pub-id>, PMID: <pub-id pub-id-type="pmid">22728827</pub-id></citation></ref>
<ref id="B30">
<label>30</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xu</surname> <given-names>X</given-names>
</name>
<name>
<surname>Jin</surname> <given-names>T</given-names>
</name>
</person-group>. <article-title>Ras inhibitors gate chemoattractant concentration range for chemotaxis through controlling GPCR-mediated adaptation and cell sensitivity</article-title>. <source>Front Immunol</source>. (<year>2022</year>) <volume>13</volume>:<elocation-id>1020117</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2022.1020117</pub-id>, PMID: <pub-id pub-id-type="pmid">36341344</pub-id></citation></ref>
<ref id="B31">
<label>31</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Futosi</surname> <given-names>K</given-names>
</name>
<name>
<surname>K&#xe1;sa</surname> <given-names>O</given-names>
</name>
<name>
<surname>Szilveszter</surname> <given-names>KP</given-names>
</name>
<name>
<surname>M&#xf3;csai</surname> <given-names>A</given-names>
</name>
</person-group>. <article-title>Neutrophil phospholipase C&#x3b3;2 drives autoantibody-induced arthritis through the generation of the inflammatory microenvironment</article-title>. <source>Arthritis Rheumatol</source>. (<year>2021</year>) <volume>73</volume>:<page-range>1614&#x2013;25</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/art.41704</pub-id>, PMID: <pub-id pub-id-type="pmid">33645887</pub-id></citation></ref>
<ref id="B32">
<label>32</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aukrust</surname> <given-names>P</given-names>
</name>
<name>
<surname>Ueland</surname> <given-names>T</given-names>
</name>
<name>
<surname>M&#xfc;ller</surname> <given-names>F</given-names>
</name>
<name>
<surname>Andreassen</surname> <given-names>AK</given-names>
</name>
<name>
<surname>Nord&#xf8;y</surname> <given-names>I</given-names>
</name>
<name>
<surname>Aas</surname> <given-names>H</given-names>
</name>
<etal/>
</person-group>. <article-title>Elevated circulating levels of C-C chemokines in patients with congestive heart failure</article-title>. <source>Circulation</source>. (<year>1998</year>) <volume>97</volume>:<page-range>1136&#x2013;43</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1161/01.CIR.97.12.1136</pub-id>, PMID: <pub-id pub-id-type="pmid">9537339</pub-id></citation></ref>
<ref id="B33">
<label>33</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schmid</surname> <given-names>S</given-names>
</name>
<name>
<surname>Le</surname> <given-names>U-T</given-names>
</name>
<name>
<surname>Haager</surname> <given-names>B</given-names>
</name>
<name>
<surname>Mayer</surname> <given-names>O</given-names>
</name>
<name>
<surname>Dietrich</surname> <given-names>I</given-names>
</name>
<name>
<surname>Elze</surname> <given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>Local concentrations of CC-chemokine-ligand 18 correlate with tumor size in non-small cell lung cancer and are elevated in lymph node-positive disease</article-title>. <source>Anticancer Res</source>. (<year>2016</year>) <volume>36</volume>:<page-range>4667&#x2013;71</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.21873/anticanres.11018</pub-id>, PMID: <pub-id pub-id-type="pmid">27630310</pub-id></citation></ref>
<ref id="B34">
<label>34</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sullivan</surname> <given-names>SE</given-names>
</name>
<name>
<surname>Staba</surname> <given-names>SL</given-names>
</name>
<name>
<surname>Gersting</surname> <given-names>JA</given-names>
</name>
<name>
<surname>Hutson</surname> <given-names>AD</given-names>
</name>
<name>
<surname>Theriaque</surname> <given-names>D</given-names>
</name>
<name>
<surname>Christensen</surname> <given-names>RD</given-names>
</name>
<etal/>
</person-group>. <article-title>Circulating concentrations of chemokines in cord blood, neonates, and adults</article-title>. <source>Pediatr Res</source>. (<year>2002</year>) <volume>51</volume>:<page-range>653&#x2013;7</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1203/00006450-200205000-00018</pub-id>, PMID: <pub-id pub-id-type="pmid">11978892</pub-id></citation></ref>
</ref-list>
</back>
</article>